Geneos Wealth Management Inc. - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 175 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,000
-50.0%
1360.0%0.00%
Q3 2018$2,0000.0%1360.0%0.00%
Q1 2018$2,0000.0%1360.0%0.00%
Q4 2017$2,000
-93.5%
136
-93.9%
0.00%
-100.0%
Q3 2017$31,000
+93.8%
2,2160.0%0.00%
+50.0%
Q2 2017$16,000
+14.3%
2,2160.0%0.00%
+100.0%
Q1 2017$14,000
+55.6%
2,216
-0.9%
0.00%0.0%
Q4 2016$9,000
-10.0%
2,2360.0%0.00%0.0%
Q3 2016$10,000
-28.6%
2,2360.0%0.00%
-50.0%
Q2 2016$14,0000.0%2,2360.0%0.00%0.0%
Q1 2016$14,0002,2360.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders